Fresno County CA header
 
File #: 15-1604    Name: Data Sharing Agreement with the California Department of Justice, Prescription Drug Monitoring
In control: Public Health
On agenda: 12/15/2015 Final action: 12/15/2015
Enactment date: Enactment #: Agreement No. 15-636
Title: Approve and authorize the Chairman to execute a no cost Data Sharing Agreement with the California Department of Justice, Prescription Drug Monitoring Program, effective upon execution ($0).
Attachments: 1. Agenda Item, 2. Agreement A-15-636 with DOJ
DATE: December 15, 2015

TO: Board of Supervisors

SUBMITTED BY: David Pomaville, Director, Department of Public Health
Dawan Utecht, Director, Department of Behavioral Health

SUBJECT: Data Sharing Agreement with the California Department of Justice

RECOMMENDED ACTION(S):
TITLE
Approve and authorize the Chairman to execute a no cost Data Sharing Agreement with the California Department of Justice, Prescription Drug Monitoring Program, effective upon execution ($0).
REPORT
The recommended Agreement will allow the Departments of Public Health and Behavioral Health (Departments) to receive aggregate and de-identified data relative to the prescribing and dispensing patterns of controlled substances by Fresno County practitioners authorized to prescribe, order, administer, furnish, or dispense controlled substances with no net County cost.

ALTERNATIVE ACTION(S):

Should your Board not approve the recommended action, the Departments would not be able to obtain aggregate and de-identified data from the California Department of Justice, Prescription Drug Monitoring Program (CA PDMP) for educational, statistical and research purposes.

FISCAL IMPACT:

There is no increase in net County cost associated with the recommended action. Through the recommended Agreement, the CA PDMP will provide de-identified datasets to the County's Public Health and Behavioral Health Departments at no cost.

DISCUSSION:

California physicians and pharmacies are required to report to the California Department of Justice, within seven days, every Schedule II, III and IV drug prescription that is written (i.e. Schedule II: ritalin, methadone and morphine; Schedule III: vicodin, ketamine and anabolic steroids; Schedule IV: valium, ambien and clonazepam). The California Substance Utilization Review and Evaluation System (CURES) database stores information regarding drug dispensed, drug quantity and strength, patient name, address, prescriber name, and authorizati...

Click here for full text